8ZMK image
Deposition Date 2024-05-23
Release Date 2025-03-12
Last Version Date 2025-03-12
Entry Detail
PDB ID:
8ZMK
Keywords:
Title:
Cryo-EM structure of BMV TLS-TyrRS (Catalysis state)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.85 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:tyrosine--tRNA ligase
Gene (Uniprot):PHAVU_002G027700g
Chain IDs:A, B
Chain Length:379
Number of Molecules:2
Biological Source:Phaseolus vulgaris
Polymer Type:polyribonucleotide
Molecule:RNA (169-MER)
Chain IDs:C
Chain Length:169
Number of Molecules:1
Biological Source:Brome mosaic virus
Ligand Molecules
Primary Citation
Structural insights into dynamics of the BMV TLS aminoacylation.
Nat Commun 16 1276 1276 (2025)
PMID: 39900568 DOI: 10.1038/s41467-025-56612-4

Abstact

Brome Mosaic Virus (BMV) utilizes a tRNA-like structure (TLS) within its 3' untranslated region to mimic host tRNA functions, aiding aminoacylation and viral replication. This study explores the structural dynamics of BMV TLS interacting with tyrosyl-tRNA synthetase (TyrRS) during aminoacylation. Using cryo-EM, we capture multiple states of the TLS-TyrRS complex, including unbound TLS, pre-1a, post-1a, and catalysis states, with resolutions of 4.6 Å, 3.5 Å, 3.7 Å, and 3.85 Å, respectively. These structural comparisons indicate dynamic changes in both TLS and TyrRS. Upon binding, TLS undergoes dynamic rearrangements, particularly with helices B3 and E pivoting, mediated by the unpaired A36 residue, ensuring effective recognition by TyrRS. The dynamic changes also include a more compact arrangement in the catalytic center of TyrRS and the insertion of 3' CCA end into the enzyme's active site, facilitating two-steps aminoacylation. Enzymatic assays further demonstrated the functional importance of TLS-TyrRS interactions, with mutations in key residues significantly impacting aminoacylation efficiency. Furthermore, Electrophoretic Mobility Shift Assay (EMSA) demonstrated that BMV TLS binds elongation factors EF1α and EF2, suggesting a multifaceted strategy to exploit host translational machinery. These findings not only enhance our knowledge of virus-host interactions but also offer potential targets for antiviral drug development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures